Top View
- The Effect of Monoamines Reuptake Inhibitors on Aerobic Exercise
- Phencyclidine (PCP) Is a Dissociative Anesthetic
- A New Strategy for Antidepressant Prescription
- Improved Forensic Toxicology Screening Using a GC/MS/NPD System with a 725-Compound DRS Database
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Combining Antidepressants Is There Any Evidence
- The Efficacy of Reboxetine As an Antidepressant, a Meta-Analysis of Both Continuous (Mean HAM-D Score) and Dichotomous (Response Rate) Outcomes
- NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
- Edronax 4 Mg Tablets Final Approved PI – 09 Sept 2009
- Synthesis of Two Testosterone Derivatives and Their Theoretical Evaluation As Serotonin Reuptake Transporter Inhibitors
- Effects of the Selective Norepinephrine Reuptake Inhibitor Reboxetine on Norepinephrine and Serotonin Transmission in the Rat Hippocampus Steven T
- Neuropharmacology of the Interoceptive Stimulus Properties of Nicotine Thomas E
- Sexual Adverse Effects with New Antidepressants
- The Specific Serotonin Reuptake Inhibitors Sertraline and Fluoxetine Promote Tumor Growth in a Mouse Xenograft Model of Cholangi
- Monday, December 4, 2006 Panel Session Co-Morbid Pain
- Single-Photon Emission Computed Tomography and Positron Emission Tomography Evaluations of Patients with Central Motor Disorders John P
- Reboxetine – a 'Nari'
- Reboxetine: a Randomized Controlled Open-Label Study in Children and Adolescents with Major Depression
- Noradrenaline Reuptake Inhibition Enhances the Antipsychotic-Like
- The Nicotinic Acetylcholine Receptor As a Target for Antidepressant Drug Development
- A Small Molecule Drug Screening Identifies Colistin Sulfate As an Enhancer of Natural Killer
- World Congress of Neurology
- Nicotinic Partial Agonists Varenicline and Sazetidine-A Have Differential Effects on Affective Behavior
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances 2009
- Des-Keto Lobeline Analogs with Increased Potency and Selectivity at Dopamine and Serotonin Transporters Guangrong Zheng, David B
- Figure S1. Rhod 2 Staining of Intracellular Calcium Depletion
- Evaluation of Agonist Pharmacotherapy for Cocaine Dependence: Effects of Continuous D-Amphetamine Treatment on Cocaine Self-Administration in Rats
- EDRONAX Tablets Contain 2.6 Mg Or 5.2 Mg Reboxetine Mesilate Corresponding to 2 Mg Or 4 Mg Reboxetine Free Base Respectively
- Brain Sciences
- Reboxetine for Treating Migraine Headaches Reboxetin Zur Behandlung Von Migränekopfschmerzen Reboxétine Pour Traiter Les Migraines
- Supplementary Information Molecules Repartition Into the Various Groups
- Regulatory Effects of Reboxetine Treatment Alone, Or Following Paroxetine Treatment, on Brain Noradrenergic and Serotonergic Systems
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Effectiveness of Medications Used to Attenuate Antipsychotic-Related Weight Gain and Metabolic Abnormalities: a Systematic Review and Meta-Analysis
- Ecstasy) Abuse Research Report
- WO 2012/170676 Al 13 December 2012 (13.12.2012) P O P C T
- Nicotinic Partial Agonists, Varenicline and Sazetidine-A, Have Differential
- Health Professionals Medications to Be Given with Caution to People With
- Cocaine and Amphetamine Increase Extracellular Dopamine in the Nucleus Accumbens of Mice Lacking the Dopamine Transporter Gene
- Title: Noradrenergic Antidepressants Increase Cortical Dopamine: Potential Use in Augmentation Strategies
- Dual Antidepressant Duloxetine Blocks Nicotinic Receptor Currents, Calcium Signals and Exocytosis in Chromaffin Cells Stimulated with Acetylcholine S
- Recent Advances in Radiotracers Targeting Norepinephrine Transporter: Structural Development and Radiolabeling Improvements
- Studies of Depression-Related States in Animal Models of Parkinsonism
- (S,S) Reboxetine for Treating Attention Deficit Disorder
- Movement Disorders: a Practical Update
- A Protocol for Systematic Review and Meta-Analysis of the Evidence Linking
- Reboxetine: a Pharmacologically Potent, Selective, and Specific Norepinephrine Reupta Ke Inhibitor
- Copyrighted Material